04.01.2013 Views

ANNUAL REPORT - Department of Biotechnology

ANNUAL REPORT - Department of Biotechnology

ANNUAL REPORT - Department of Biotechnology

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

An Overview<br />

<strong>Biotechnology</strong> is a set <strong>of</strong> rapidly emerging and far<br />

reaching new technologies with great promise in<br />

areas <strong>of</strong> sustainable food production, nutrition<br />

security, health care and environmental<br />

sustainability. Our vision is to use powerful tools <strong>of</strong><br />

biotechnology to help convert the country's diverse<br />

biological resources to useful products and<br />

processes that are accessible to its masses for<br />

economic development and employment generation.<br />

<strong>Biotechnology</strong> is globally recognized as a rapidly<br />

emerging, complex and far reaching new technology.<br />

<strong>Biotechnology</strong> can, over the next two decades,<br />

deliver the next wave <strong>of</strong> technological change that<br />

can be as radical and pervasive as that brought about<br />

by IT. The recent and continuing advances in life<br />

sciences clearly unfold a scenario energized and<br />

driven by the new tools <strong>of</strong> biotechnology. The<br />

convergence <strong>of</strong> advances in biology genomics,<br />

proteomics, bioinformatics and information<br />

technologies is driving the emergence <strong>of</strong> a new<br />

bioeconomy.During the last five years, biotechnology<br />

industry has been growing at a rate <strong>of</strong> 40% and in<br />

2005-06 exceeded US$ 1.5 billion in turnover.<br />

Though the growth was achieved mainly through<br />

leadership in biogenerics and contract<br />

manufacturing, research leading to innovative<br />

product development did not lag behind. The social<br />

impact <strong>of</strong> such growth is evident from India assuming<br />

a dominant place in vaccine exports, diagnostics,<br />

transgenics (Bt Cotton) and a number <strong>of</strong><br />

biotherapeutics. There is a projection <strong>of</strong> an annual<br />

turnover <strong>of</strong> US $ 10 billion for India by 2010 and a<br />

speculated about 25% annual growth rate between<br />

2010 and 2015.During the year 2006-07, the impetus<br />

has been on programmes <strong>of</strong> national relevance with<br />

special emphasis on strengthening <strong>of</strong> infrastructure,<br />

creation <strong>of</strong> centers <strong>of</strong> excellence, capacity building<br />

and developing mission mode programmes and<br />

public-private partnerships. Over 450 R&D projects<br />

have been supported during the year with<br />

approximately 200 universities and research<br />

laboratories being provided the necessary support in<br />

1<br />

Chapter-1<br />

terms <strong>of</strong> both capacity building and infrastructure<br />

strengthening.In the area <strong>of</strong> health care, new<br />

vaccines and diagnostics have been indigenously<br />

developed and are under clinical trials. A major<br />

initiative has been taken to develop stem cell<br />

research in the country and 6 centres have received<br />

programme support. A road map has been<br />

formulated and city clusters established to forge<br />

interdisciplinary collaboration, crucial to this sector.<br />

Cutting edge research in areas <strong>of</strong> tissue engineering,<br />

bio-medical devices, biomaterials, nanobiotechnology<br />

and RNAi is being supported. A<br />

special initiative for devices and formulation required<br />

for a national programme on maternal, neonatal and<br />

child health has been initiated. In the area <strong>of</strong><br />

agriculture biotechnology the focus is on nutritional<br />

enhancement, increased productivity and<br />

development <strong>of</strong> crops resistant to biotic and abiotic<br />

stresses. Establishing Centres <strong>of</strong> Excellence has<br />

received special attention during the current year to<br />

achieve reengineering <strong>of</strong> certain institutes for greater<br />

innovation and focus. The societal development<br />

programme has received special attention and<br />

benefited more than 20,000 SC/ST population,<br />

women and rural population during the year. The<br />

efforts were focused to create enably circumstances<br />

for increasing access <strong>of</strong> common people to new<br />

technologies and products and promoting the mass<br />

use <strong>of</strong> these technologies for healthcare, nutritional<br />

security, employment generation and environmental<br />

well being.Life science and biotechnology sector is<br />

characterized by dynamic changes in flow <strong>of</strong> new<br />

idea and conception and development <strong>of</strong> new tools<br />

for research. Rapid responses are required to meet<br />

these challenges. A number <strong>of</strong> new initiatives has<br />

been taken up during the year to achieve this goal,<br />

which include increased number <strong>of</strong> Ph.D., post-docs<br />

including overseas fellowships, rapid grants for<br />

young investigators, innovation fellowships etc. A<br />

major success during the current year has been the<br />

launch <strong>of</strong> public/private partnership scheme Small<br />

Business Innovation Research Initiative (SBIRI),<br />

An Overview

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!